We are live on ! Find out more
DCM

DAFNA Capital Management Portfolio holdings

AUM $440M
1-Year Est. Return 109.12%
This Fund
S&P 500
This Quarter Est. Return
+9.7%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$97.2M
AUM Growth
+$5.62M
Cap. Flow
+$348K
Cap. Flow %
0.36%
Top 10 Hldgs %
67.75%
Holding
59
New
8
Increased
8
Reduced
8
Closed
10

Top Buys

Rank Stock Value
1
WINT
Windtree Therapeutics Inc
WINT
+$8.21M
2
NXTM
NxStage Medical Inc.
NXTM
+$1.5M
3
MTEM
Molecular Templates, Inc.
MTEM
+$1.28M
4
ACHV icon
Achieve Life Sciences
ACHV
+$895K
5
PCYC
PHARMACYCLICS INC
PCYC
+$789K

Top Sells

Rank Stock Value
1
ARIA
Ariad Pharmaceuticals Inc
ARIA
+$2.74M
2
CRIS icon
Curis
CRIS
+$1.3M
3
KBIO
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
+$1.13M
4
BEAT
BioTelemetry, Inc.
BEAT
+$867K
5
RXII
GALENA BIOPHARMA INC COM
RXII
+$855K

Sector Composition

Rank Sector Weight
1 Healthcare 57.39%
2 Financials 1.3%
3 Communication Services 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARIA
51
DELISTED
Ariad Pharmaceuticals Inc
ARIA
– –
-148,915
Closed -$2.74M
ADAT
52
DELISTED
AUTHENTIDATE HOLDING CORP COM STK (DE)
ADAT
– –
-15,785
Closed -$126K
TGX
53
DELISTED
THERAGENICS CORP
TGX
– –
-160,719
Closed -$350K
RXII
54
DELISTED
GALENA BIOPHARMA INC COM
RXII
– –
-375,000
Closed -$855K
KBIO
55
DELISTED
KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO
– –
-31,250
Closed -$1.13M
GRMH
56
DELISTED
GRAYMARK HEALTHCARE INC COM STK NEW (OK)
GRMH
– –
-693,027
Closed -$284K
1 2
3

Similar funds

CDMG
Creek Drive Management Group San Francisco, California $439M AUM
STCG
Speece Thorson Capital Group Minnetonka, Minnesota $439M AUM 10.15% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
HCM
Harvey Capital Management Palm Beach, Florida $439M AUM 37.68% 1-Year Est. Return
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
ECA
Endeavour Capital Advisors Greenwich, Connecticut $441M AUM 21.38% 1-Year Est. Return
WAS
Winch Advisory Services Appleton, Wisconsin $438M AUM 17.59% 1-Year Est. Return

DAFNA Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, DAFNA Capital Management held 59 positions worth $97.2M, up 6.1% from $91.5M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

DAFNA Capital Management's Q4 2013 filing shows 8 new, 8 increased, 8 reduced and 10 closed positions. Its largest new stake was Molecular Templates, Inc.: 1,700 shares worth $1.31M. The largest sale was Ariad Pharmaceuticals Inc, an estimated $2.74M.

By sector, the portfolio is most concentrated in Healthcare at 57% of assets, down from 60% a quarter earlier, followed by Financials and Communication Services.

  • DAFNA Capital Management's largest Q4 2013 buy was Molecular Templates, Inc.: 1,700 shares worth $1.31M.
  • DAFNA Capital Management added most to Windtree Therapeutics Inc in Q4 2013, an estimated $8.21M increase.
  • DAFNA Capital Management's biggest Q4 2013 reduction was Curis, cutting an estimated $1.3M.
  • DAFNA Capital Management fully exited Ariad Pharmaceuticals Inc in Q4 2013, selling an estimated $2.74M.
  • DAFNA Capital Management's ten largest holdings make up 68% of its $97.2M portfolio in Q4 2013.
  • DAFNA Capital Management opened 8 new positions and closed 10 in Q4 2013.
  • DAFNA Capital Management's portfolio value rose 6.1% quarter-over-quarter to $97.2M.

Based on DAFNA Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.